Intarcia Provides Corporate Update

BOSTON, Sept. 27, 2017 /PRNewswire/ -- Intarcia Therapeutics, Inc., a privately held biopharmaceutical company committed to developing innovative therapies to enhance treatment and prevention outcomes in serious chronic diseases, today announced that the U.S. Food and Drug Administration (...